
The Review literature about Chondroblastoma with a case on Talus bone
Author(s) -
Sayed Abdulla Jami,
AUTHOR_ID,
Siam Al Mobarak,
Masood Tanvir,
Syma Nosin,
AUTHOR_ID,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2020
Publication title -
hong kong journal of orthopaedic research
Language(s) - English
Resource type - Journals
eISSN - 2663-8231
pISSN - 2663-8223
DOI - 10.37515/ortho.8231.3306
Subject(s) - chondroblastoma , curettage , radiological weapon , medicine , bone grafting , radiology , surgery , differential diagnosis , epidemiology , pathology
Background: Chondroblastomas are rare bone tumors, which are the cartilaginous origin and account for nearly 1% of all primary bone tumors. It can affect people of all ages. Chondroblastomas arising in the talus are very rare and are known to have less aggressive behavior. Methods: 11 authors, a total of 572 patient data with our talus case, were analyzed for this review literature. Here is the mentioning of epidemiological and clinical information, radiological details, surgery type, adjuvants types, genders, follow-up years, recurrence, affected areas, death rates, successful outcome, MSTS functionality scores, and survival rates by analyzing all data. Result: Chondroblastoma was treated by curettage and bone grafting during surgical procedures. This procedure is curative in 90% of cases. There was no recurrence in this study case of the talus. Also, the MSTS functionality score for CB averages 90% more in most of the author’s literature, and 0% death rate was reported. Conclusion: We believe that chondroblastoma of the talus bone should be considered among the differential diagnosis whenever a neoplastic cause is being considered as the underlying pathologic entity. We present a review of the literature detailing their occurrence, radiological findings, and treatments and to report functional outcomes after treatments, which have been rarely documented in a large series.